Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

New Eisai venture arm to focus on digital tech, dementia, cancer

Chris Lieu, Staff Writer
May 10, 2019 8:15 PM UTC

As Eisai looks to digital technologies for dementia drug discovery, the Japanese pharma’s newly launched venture arm has made its first investment and backed Tokyo-based digital healthcare company Allm.

Eisai Co. Ltd. (Tokyo:4523) said the investment arm will invest in and partner with biopharma, diagnostic and IT companies, as well as government agencies, medical facilities and insurance companies to evaluate real world, genomic and clinical data for drug discovery in neurology and oncology...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Eisai Co. Ltd.